PKU International Healthcare Group, Shanghai Medicilon Inc., SK Biopharmaceuticals deal

SK and CRO Medicilon amended a 2011 deal. Under the amended deal, PKU's Southwest Synthetic Pharmaceuticals and PKUCare Pharmaceutical R&D Center subsidiaries will join Medicilon and SK to start clini...